Wilms' tumor epidemiology and demographics

Revision as of 19:03, 25 August 2015 by Shanshan Cen (talk | contribs)
Jump to navigation Jump to search

Wilms' tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Wilms' Tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Wilms' tumor epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Wilms' tumor epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Wilms' tumor epidemiology and demographics

CDC on Wilms' tumor epidemiology and demographics

Wilms' tumor epidemiology and demographics in the news

Blogs on Wilms' tumor epidemiology and demographics

Directions to Hospitals Treating Wilms' tumor

Risk calculators and risk factors for Wilms' tumor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Epidemiology and Demographics

Wilms tumours are the most common paediatic renal mass, accounting for over 85% of cases and accounts for 6% of all childhood cancers. It typically occurs in early childhood (1-11 years) with peak incidence between 3 and 4 years of age. Approximately 80% of these tumours are found before the age of 5 years. When part of a syndrome (see below) they occur even earlier, typically between 2 and 24 months of age.

There is no recognised gender predilection, however, presentation is a little later in females. The vast majority are unilateral with less than 5 % occurring bilaterally.[1]

References

  1. Wilms tumour. Dr Tim Luijkx and Dr Frank Gaillard et al. Radiopaedia.org 2015.http://radiopaedia.org/articles/wilms-tumour

Template:WH Template:WS